Recurrent major infections in juvenile-onset systemic lupus erythematosus - A close link with long-term disease damage

Rheumatology

Volumn 46, Issue 8, 2007, Pages 1290-1296

  Lee, P P W ^a   Lee, T L ^a   Ho, M H K ^a   Wong, W H S ^a   Lau, Y Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Children; Infections; SLE; SlE Damage Index

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DRUG MEGADOSE; FEMALE; HUMAN; INFECTIOUS COMPLICATION; LOGISTIC REGRESSION ANALYSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; ONSET AGE; ORGAN INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; UNIVARIATE ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 34547830793     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem102     Document Type: Article

References (33)

1. Klein-Gitelman M, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am 2002;28:561-77.
2. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577-87.
3. Tucker LB, Menon S, Schaller JG, Isenberg DA. Adult and childhood-onset systemic lupus erythematosus: A comparison of onset, clinical features, serology and outcome. Br J Rheum 1995;34:866-72.
4. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival in Southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine 2005;84:218-24.
5. Costallat LTL, Coimbra AMV. Systemic lupus erythematosus: Clinical and laboratory aspects related to age at disease onset. Clin Exp Rheumatol 1994;12:603-7.
6. Font J, Cervera R, Espinosa G et al. Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998;57:456-59.
7. Perfumo F, Martini A. Lupus nephritis in children. Lupus 2005;14:83-8.
8. Wang LC, Yang YH, Lu MY, Chiang BL. Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect 2003;36:203-8.
9. Ravelli A, Duarte-Salazar C, Buratti S et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: A multicentre cohort study. Arthritis Rheum 2003;49:501-7.
10. Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin N Am 2005;52:443-67.
11. Mok CC, Lee KW, Ho CTK, Lau CS, Wong RWS. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology 2000;39:399-406.
12. Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus. Curr Opin Rheumatol 2005;17:568-73.
13. Petri M. Infection in systemic lupus erythematosus. Rheum Dis Clin N Am 1998;24:440-7.
14. Cervera R, Khamashta M, Font J et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: A multicenter prospective study of 1000 patients. Medicine 1999;78:167-75.
15. Fessler BJ. Infectious diseases in systemic lupus erythematosus: Risk factors, management and prophylaxis. Best Pract Res Clin Rheum 2002;16:281-91.
16. Ginzler E, Diamond H, Kaplan D et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978;21:37-44.
17. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2002;46:436-44.
18. Lilleby V, Flato B, Forre O. Disease duration, hypertension and medication requirements are associated with organ damage in childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2005;23:261-9.
19. Tan EM,, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
21. Gladman DID, Ginzler E, Goldsmith CH et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
22. Lee PPW, Lee TL, Ho MHK, Wong WHS, Lau YL. Herpes zoster in juvenile-onset systemic lupus erythematosus: Incidence, clinical characteristics and disk factors. Pediatr Infect Dis J 2006;25:728-32.
23. Miettunen PM, Ortiz-Alvarez O, Petty RE et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rhuematol 2004;31:1650-4.
24. Hagelberg S, Lee Y, Bergman J et al. Longterm followup of childhood lupus nephritis. J Rheumatol 2002;29:2635-42.
25. Bogdanovic R, Nikolic V, Pasi S et al. Lupus nephritis in childhood: A review of 53 patients followed at single center. Pediatr Nephrol 2004;19:36-44.
26. Zonana-Nacach A, Camargo-Coronel A, Yanez P et al. Infections in outpatients with systemic lupus erythematosus: A prospective study. Lupus 2001;10:505-10.
27. Gladman DD, Hussain F, Ibanaez D, Urowitz MB. The nature and outcome of infection in systemic lupus erythematosus. Lupus 2002;11:234-9.
28. Yuhara T, Takemura H, Alkama T. Predicting infection in hospitalized patients with systemic lupus erythematosus. Internal Med 1996;35:629-36.
29. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 1991;18:1180-4.
30. Noel V. Lortholary O, Casassus P et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 2001;60:1141-4.
31. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroid for systemic lupus erythematosus. Arthritis Rheum 1996;39:1475-82.
32. Chen YS, Yang YH, Lin YT, Chiang BL. Risk of infection in hospitalized children with systemic lupus erythematosus: A 10-year follow-up. Clin Rheumatol 2004;23:235-8.
33. Gutierrez-Suarez R, Ruperto N, Gastaldi R et al. A proposal for a Pediatric Version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2006;54:2989-96.